
doi: 10.3909/ricm0552
pmid: 21546886
Statins are frequently used as chronic therapy for reducing cardiovascular mortality and morbidity, but there has been less emphasis on the role of statins in the perioperative period. This review evaluates data regarding statin use in vascular and noncardiac surgery, the use of statins in combination with β-blockers in the perioperative period, perioperative statin use in patients already treated with statins, and the safety of statin therapy in the perioperative period. Current recommendations state that patients who are prescribed statins as chronic therapy should continue treatment in the perioperative period, but data suggest that there may be benefit from the use of perioperative statins in a wider population.
Treatment Outcome, Surgical Procedures, Operative, Adrenergic beta-Antagonists, Practice Guidelines as Topic, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Perioperative Period, Risk Assessment, Vascular Surgical Procedures
Treatment Outcome, Surgical Procedures, Operative, Adrenergic beta-Antagonists, Practice Guidelines as Topic, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Perioperative Period, Risk Assessment, Vascular Surgical Procedures
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
